{
    "resourceType": "Bundle",
    "id": "bundle-transaction",
    "meta": {
        "lastUpdated": "2018-08-29T15:44:07.033-04:00"
    },
    "type": "transaction",
    "entry": [
        {
            "fullUrl": "urn:uuid:429c929f-9856-4f85-8c73-15657619f24d",
            "resource": {
                "resourceType": "ResearchStudy",
                "meta": {
                    "versionId": "1",
                    "lastUpdated": "2018-08-24T15:17:25.439-04:00"
                },
                "title": "Eli Lilly Test Study 2018",
                "protocol": [
                    {
                        "identifier": {
                            "use": "secondary",
                            "type": {
                                "text": "A2Z-TC-RWEA"
                            },
                            "system": "http://ct.gov/Z5Z-ZZ-CAGN",
                            "value": "A2Z-TC-RWEA",
                            "period": {
                                "start": "2018-05-04T12:18:25.356Z",
                                "end": "2018-10-04T12:18:25.356Z"
                            },
                            "assigner": {
                                "display": "Organization Eli Lilly"
                            }
                        },
                        "display": "The A2Z-TC-RWEA study is a 4-6 week study where the participants will track pain experienced while going through cancer treatment."
                    }
                ],
                "status": "in-progress",
                "contact": [
                    {
                        "name": "Eli Lilly and Company"
                    }
                ],
                "jurisdiction": [
                    {
                        "coding": [
                            {
                                "system": "http:/ct.gov",
                                "code": "US2",
                                "display": "United States",
                                "userSelected": true
                            }
                        ],
                        "text": "United States Study"
                    }
                ],
                "description": "Measures pain level during cancer treatment",
                "period": {
                    "start": "2018-05-04T12:18:25.356Z",
                    "end": "2018-10-04T12:18:25.356Z"
                },
                "sponsor": {
                    "reference": "Organization/TNCL9960",
                    "display": "Eli Lilly and Company"
                },
                "principalInvestigator": {
                    "reference": "Practitioner/TNCL94301579",
                    "display": "Phoebe Buffay, MD"
                }
            },
            "request": {
                "method": "PUT",
                "url": "ResearchStudy/A2Z-TC-RWEA"
            }
        }
    ]
}
